Paris-based Waiv, which uses AI to enable more precise testing of cancer, raised $33M after spinning out of AI diagnostics and drug discovery platform Owkin news sifted.eu

Martin Coulter / Sifted: Paris-based Waiv, which uses AI to enable more precise testing of cancer, raised $33M after spinning out of AI diagnostics and drug discovery platform Owkin  —  French healthtech aims to revolutionise cancer screening  —  Waiv, a Paris-based medical testing startup spun out of biotech unicorn Owkin …